Medication info
Raviet 10 mg (Rabeprazole Sodium)

Raviet 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Pale yellow-pink round enteric-coated tablet
Packaging
28 tablets/box [(14 tablets/PPT *2)]
Approval status
Active

MFDS item code 200807539 · Notified 2008.07.08 · Insurance code 642902880

Summary

Main use
Treatment of reflux disease and ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using an on-demand regimen of 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: It is recommended that this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g be administered concomitantly twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of reflux disease and ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective for the treatment of gastric ulcers and duodenal ulcers. Additionally, it alleviates symptoms of erosive or ulcerative gastroesophageal reflux disease and can be used for long-term maintenance therapy of gastroesophageal reflux disease. For patients with gastrointestinal ulcers infected with Helicobacter pylori, it can be administered in combination with antibiotics. It is also effective for conditions like Zollinger-Ellison syndrome, which involves excessive gastric acid secretion. It is used to improve and treat various gastrointestinal disorders.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using an on-demand regimen of 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: It is recommended that this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g be administered concomitantly twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Precautions

This medication should not be used in patients with a history of allergy to this medication or any of its components, or hypersensitivity to benzimidazole derivatives. Additionally, it is safer not to administer it to patients taking certain antibiotics or medications, as well as to pregnant or breastfeeding women. Caution should be exercised when using this medication in patients with liver dysfunction or the elderly. This medication can cause various side effects such as skin rash, itching, blood disorders, liver function abnormalities, etc., so if any unusual symptoms arise, the medication should be stopped immediately and medical attention should be sought. Long-term use requires regular blood tests and liver function tests. This medication may slightly increase the risk of bacterial infections in the gastrointestinal tract by suppressing gastric acid secretion; therefore, if symptoms such as diarrhea persist, consult a doctor. Care should be taken as drowsiness may occur during driving or machinery operation. There may be drug interactions, so if you are taking other medications, be sure to notify your healthcare provider. Pregnant or breastfeeding individuals should not use this medication, and if necessary, must consult a professional. Safety has not been established in children, so it is not used in pediatric patients. There are no specific antidotes for overdose, so appropriate treatment should be administered based on symptoms, and tablets should not be chewed or crushed but swallowed whole. Keep this medication out of reach of children and do not transfer to other containers. Long-term use of this medication may increase the risk of osteoporosis-related fractures, so caution is advised. Additionally, hypomagnesemia may occur, so regular monitoring of magnesium levels is needed during prolonged use.

Side effects

Rash, hives, itching, anemia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, block of conduction, palpitations, arrhythmia, tachycardia, bradycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, irritability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, excessive circulatory blood volume, upper and lower limb weakness, sensory hypoestesia, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, nosebleeds, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, sleep apnea, respiratory depression, interstitial pneumonia, muscle pain, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, excessive muscle tension, neuralgia, isolated contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, difficulty urinating, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, epididymitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, increased serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, malaise, weight gain, visual disturbances, loss of appetite, nuchal rigidity, photosensitivity reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, vascular edema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fractures, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness and safety.

Appearance and packaging

Appearance

Pale yellow-pink round enteric-coated tablet

Package unit

28 tablets/box [(14 tablets/PPT *2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.